Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
26.81
+0.06 (0.22%)
At close: Jun 27, 2025, 4:00 PM
26.58
-0.23 (-0.86%)
After-hours: Jun 27, 2025, 7:47 PM EDT

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Market Capitalization
7,428---
Enterprise Value
7,815---
Debt / Equity Ratio
-1.19-1.53-11.041.08
Asset Turnover
-1.090.54-
Inventory Turnover
-5.244.48-
Quick Ratio
0.700.931.863.29
Current Ratio
1.051.302.553.77
Return on Equity (ROE)
---293.82%-
Return on Assets (ROA)
--42.48%-35.34%-
Return on Capital (ROIC)
--93.29%-55.45%-
Buyback Yield / Dilution
--1.59%-4.73%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q